Carcinoid heart disease: current understanding and future directions

Area of Science:

• Oncology
• Cardiology
• Endocrinology

Background:

• Carcinoid tumors are rare, aggressive malignancies.
• Vasoactive agents from tumors cause systemic effects.
• Cardiac dysfunction significantly reduces quality of life and survival.

Purpose of the Study:

• To highlight the importance of early detection and surgical referral for carcinoid tumors.
• To emphasize the high incidence of cardiac involvement at clinical presentation of carcinoid syndrome.
• To discuss current therapeutic limitations and their impact on survival.

Main Methods:

• Review of existing literature on carcinoid tumors and carcinoid syndrome.
• Analysis of the impact of vasoactive agents on systemic and cardiac health.
• Evaluation of treatment outcomes for medical versus surgical interventions.

Main Results:

• 50% of patients present with cardiac involvement by the time carcinoid syndrome is diagnosed.
• Medical therapies like somatostatin analogues provide symptomatic relief but no mortality benefit.
• Early surgical intervention following prompt recognition is associated with increased survival.

Conclusions:

• Prompt recognition and diagnosis of carcinoid tumors are crucial.
• Surgical referral offers a survival benefit, unlike current medical therapies.
• Addressing cardiac dysfunction is vital for improving outcomes in carcinoid syndrome.